November 14, 2018 — SuperSonic Imagine recently exhibited at The Liver Meeting, held Nov. 9-13 in San Francisco, where the company introduced the U.S. Food and Drug Administration (FDA)-cleared Aixplorer Mach 30 ultrasound imaging system. Furthermore the Aixplorer SWE has also been cleared by the FDA as an aid to clinical management of adult and pediatric patients with liver disease such as fibrosis and steatosis.
In addition to routine morphological and hemodynamic imaging, Aixplorer systems can quickly and reliably image and measure liver stiffness in real-time under image guidance, utilizing the platform’s ShearWave Elastography (SWE) technology, a 60-second non-invasive exam. Liver stiffness is known to be correlated to liver fibrosis severity and is therefore considered a critical non-invasive biomarker of disease severity. A recent clinical study demonstrated that SWE could reduce the need for liver biopsies by 80 percent in patients with inactive chronic infection.[1]Aixplorer can also compare ultrasound liver brightness to reference tissue to gain a hepato-renal brightness ratio, which indicates the extent of hepatic steatosis. Aixplorer’s ability to visualize and quantify abdominal vascularization and perfusion aids clinical management of adult patients with liver nodules and advanced chronic liver diseases as well.
The Aixplorer Mach 30 is tailored to meet the needs of liver specialists. It includes the newest version of SuperSonic Imagine’s imaging modes and tools, such as real-time ShearWave Elastography (SWE PLUS), B Mode Ratio to detect intrahepatic steatosis, Angio PL.U.S. with high resolution for imaging microvascularization in lesions, as well as Doppler and contrast imaging for the screening and characterization of liver nodules. A new available high-frequency, single-crystal curved transducer can visualize narrow intercostal spaces without compromising penetration. The Aixplorer Mach 30’s SonicPad makes exams more efficient, cutting times by up to 32 percent while allowing physicians to concentrate on the image and the patient, not the controls. SonicPad also uses intuitive gestures to reduce movement by an average 70 percent.
The Aixplorer Mach 30 will be on display at the 2018 Radiological Society of North America (RSNA) annual meeting, Nov. 25-30 in Chicago.
For more information: www.supersonicimagine.com
October 07, 2026 
